tradingkey.logo
tradingkey.logo
Search

Oragenics Inc

OGEN
Add to Watchlist
0.366USD
-0.033-8.27%
Close 10-27 16:00(ET)
1.65MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)0.366USD-0.008-2.14%

Oragenics Inc (OGEN) Stock Price Target & Forecast

Target Price
2.000USD+308.00%

OGEN Analyst Recommendation Trends

In the current month, OGEN has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OGEN average Analyst price target in the last month is 2.000.

2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
Strong Buy
0
0
0
0
0
0
0
0
Buy
0
0
0
0
0
1
1
1
Hold
0
0
0
0
0
0
0
0
Strong Sell
0
0
0
0
0
0
0
0
Sell
0
0
0
0
0
0
0
0
Total
0
0
0
0
0
1
1
1

OGEN Analyst Rating for Peer Comparison

Updated: Oct 27, 2026
Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Ratings
Analysts
Beigene Ltd
ONC
8
19
0
0
0
27
argenx SE
ARGX
10
14
3
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Biontech SE
BNTX
4
12
8
0
0
24
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
Forecast
--
--
--
Actual
-0.54
-0.51
-0.57
Surprise
--
--
--

FAQs

What is Oragenics Inc's price target?

Analysts forecast that Oragenics Inc's price target is USD 2.00, with the highest forecast at USD 2.00 and the lowest forecast at USD 2.00.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.